Cross-reactivity of acetylfentanyl and risperidone with a fentanyl immunoassay

Journal of Analytical Toxicology

Volumn 38, Issue 9, 2014, Pages 672-675

  Wang, Bei Tzu ^a   Colby, Jennifer M ^a   Wu, Alan H B ^a   Lynch, Kara L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLFENTANYL; DRUG METABOLITE; FENTANYL; FENTANYL DERIVATIVE; PALIPERIDONE; RISPERIDONE; UNCLASSIFIED DRUG; ISOXAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ARTICLE; CROSS REACTION; DIAGNOSTIC KIT; EMERGENCY PATIENT; EMERGENCY WARD; FALSE POSITIVE RESULT; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDATION STUDY; LABORATORY DIAGNOSIS; PROCEDURES; REPRODUCIBILITY; SUBSTANCE ABUSE; SUBSTANCE-RELATED DISORDERS; UNITED STATES; URINE;

CHROMATOGRAPHY, LIQUID; CROSS REACTIONS; FALSE POSITIVE REACTIONS; FENTANYL; HUMANS; IMMUNOASSAY; ISOXAZOLES; PYRIMIDINES; REPRODUCIBILITY OF RESULTS; RISPERIDONE; SAN FRANCISCO; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TANDEM MASS SPECTROMETRY;

EID: 84913601217     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bku103     Document Type: Article

References (16)

1. Jaffe, J.H., Martin, W.R.(1985) Opioid analgesics and antagonists. In: Gilman, S.G., Goodman, L.S., Rail, T.W., Murad, F. (eds), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 7th edition, Macmillan: New York, 491-531.
2. Nelson, L., Schwaner, R. (2009) Transdermal fentanyl: pharmacology and toxicology. Journal of Medical Toxicology, 5, 230-241.
3. Randall, C.B., Robert, H.C. (2004) Disposition of Toxic Drugs and Chemicals in Man, 7th edition. Biomedical Publications, Foster City, p. 451.
4. Stanley, T.H. (1992) The history and development of the fentanyl series. Journal of Pain and Symptom Management, 7, S3-S7.
5. CDC. MMWR. Nonpharmaceutical Fentanyl-related Deaths-Multiple States, April 2005-March 2007. 25 July 2008, 57, 793-796. http:// www.cdc.gov/mmwr/preview/mmwrhtml/mm5729a1.htm (accessed April, 2014).
6. Krinsky, C.S., Lathrop, S.L., Crossey, M., Baker, G., Zumwalt, R. (2011) A toxicology-based review of fentanyl-related deaths in New Mexico (1986-2007). American Journal of Forensic Medicine Pathology, 32, 347-351.
7. CDC. MMWR.Acetylfentanyl Overdose Fatalities-Rhode Island, March-May 2013. 30 August 2013, 62, 703-704. http://www.cdc. gov/mmwr/preview/mmwrhtml/mm6234a5.htm (accessed April, 2014).
8. CDC Health Alert Network. Recommendation for Laboratory Testing for Acetylfentanyl and Patient Evaluation and Treatment for Overdose with Synthetic Opioids.2013, 00350. http://www.bt.cdc.gov/HAN/ han00350.asp (accessed April, 2014).
9. Pennsylvania; Department of Drug and Alcohol Programs. Department of Drug and Alcohol Programs Warns about Acetylfentanyl: Drug Caused at least 50 Fatalities This Year in Pennsylvania (27 June 2013). http://www.portal.state.pa.us/portal/server.pt/gateway/ PTARGS_0_2_1345188_0_0_18/Department%20of%20Drug%20and %20Alcohol%20Programs%20Warns%20about%20Acetyl%20Fentanyl. pdf (accessed April, 2014).
10. North Carolina Department of Health and Human Services. DHHS Issue Health Advisory for Deadly New Synthetic Drug: Acetylfentanyl Detected in Specimens Associated with Three N.C. Death This Year (19 February 2014). http://www.ncdhhs.gov/ pressrel/2014/2014-02-19_health_advisory.htm (accessed April, 2014).
11. Labroo, R.B., Paine, M.F., Thummel, K.E., Kharasch, E.D. (1997) Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metabolism and Disposition, 25, 1072-1080.
12. Snyder, M.L., Jarolim, P., Melanson, S.E. (2011) A newautomated urine fentanyl immunoassay: technical performance and clinical utility for monitoring fentanyl compliance. Clinica Chimica Acta, 412, 946-951.
13. Ruangyuttikarn, W., Law, M.Y., Rollins, D.E., Moody, D.E. (1990) Detection of fentanyl and its analogs by enzyme-linked immunosorbent assay. Journal of Analytical Toxicology, 14, 160-164.
14. Gardner, D.M., Baldessarini, R.J., Waraich, P. (2005) Modern antipsychotic drugs: a critical overview. Canadian Medical Association Journal, 172, 1703-1711.
15. Bishop, J.R., Pavuluri, M.N. (2008) Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia neuropsychiatric disease and treatment. Neuropsychiatry Disease and Treatment, 4, 55-68.
16. Springfield, A.C., Bodiford, E. (1996) An overdose of risperidone. Journal of Analytical Toxicology, 20, 202-203.